全球医疗人体增强市场：仿生学、器官/身体部位替换、外骨骼、机器人（2023-2028）

本报告审视了全球医疗人体增强市场，并提供技术评估、产品和服务评论、应用评估、行业影响评估、竞争分析等。

内容

第 1 章执行摘要

第 2 章简介

• 仿生学概述
• 仿生产品及应用行业
• 仿生学的驱动因素
  • 医疗技术的进步
  • 人口老龄化导致器官衰竭增加
  • 切割事故
  • 外骨骼的用途
  • 机器人替代品
  • 政府研发计划
  • 收入增加，尤其是在新兴国家
• 仿生市场的製约因素
  • 设备和治疗成本高昂
  • 政府监管和严格的审批流程
  • 缺乏外科专业知识
• 仿生学对社会的影响
  • 积极影响
  • 负面影响

第三章仿生技术与市场发展

• 医疗仿生产品
• 矫形器/假肢
• 人工器官
• 强化外骨骼
  • 医疗外骨骼
  • 军用外骨骼
  • 辅助外骨骼
• 人体仿生学
• 机械与电子仿生学
• 人工植入物与可穿戴仿生设备
• 3D 打印和仿生学
• 仿生学和人工智能
• 纳米技术和仿生学
• 商业仿生学
• 控制论有机体
• 仿生产业现状

第 4 章用例

• HELLEN - 外骨骼
• 癫痫发作跟踪和预测
• 适合健身的外骨骼设计
• 机器人外骨骼案例研究
• 重走外骨骼
• 磁性编码器可以构建“改变生活”的外骨骼
• 靛蓝外骨骼

第五章人体增强市场分析与利润预测

• 仿生总收入（2023-2028 年）
• 按行业划分的仿生学收入（2023-2028 年）
• 医疗仿生学收入（2023-2028 年）
  • 按产品类别划分的医疗仿生学收入
  • 按应用类型划分的医疗仿生学收入
  • 按产品类型划分的植入式医疗仿生学收入
  • 按技术类型划分的医疗仿生学收入
  • 按产品类型划分的医疗机械仿生收入
  • 按最终用户类型划分的医疗仿生学收入
  • 医疗仿生学收入：按地区分类
  • 北美医疗仿生学收入：按国家/地区分类
  • 欧洲医疗仿生学收入：按国家分类
  • 亚太地区医疗仿生学收入：按国家/地区划分
  • 拉丁美洲/中东/非洲的医疗仿生学收入：按国家/地区分类
• 国防外骨骼仿生收入（2023-2028）
  • 按产品类别划分的国防外骨骼仿生收入
  • 按技术类型划分的国防外骨骼仿生收入
  • 国防外骨骼仿生收入：按地区
  • 北美国防外骨骼仿生收入（按国家/地区划分）
  • 亚太地区国防外骨骼仿生收入：按国家分类
  • 欧洲国防外骨骼仿生学收入（按国家划分）
  • 世界其他地区用于国防的外骨骼仿生学收入：按国家/地区划分

第六章公司及分析

• 策略建议
• Abbott Laboratories
• AbbVie Inc.
• Abiomed
• Asahi Kasei Kuraray Medical Co. Ltd.
• Baxter International
• Zimmer Biomet Holdings
• Boston Scientific Corporation
• Cochlear Ltd.
• Edwards Lifesciences Corporation
• Ekso Bionics Holdings Inc.
• LivaNova PLC
• Medtronic plc
• Orthofix Holdings Inc.
• Otto Bock HealthCare GmBH
• Sonova Holding AG
• Ossur Corporate
• SynCardia Systems LLC
• Bionic Power
• ExoAtlet
• Lockheed Martin Corporation
• RB3D
• Sarcos Corporation
• Spring Active
• SRI International

第七章结论与市场展望

Human Augmentation represents mechanical and electronic additions to the human body to improve various body functions. In the healthcare sector, augmentation may include bionics, organ replacement, exoskeletons, and robotics to provide assistance to those that have physical impairments. The goals of augmentation are many and varied such as rehabilitation, elder care, work and lifestyle enablement.

In many cases, the goal is to replicate biological methods and systems found in nature via electrically or mechanically powered artificial devices. Examples range from artificial organ or body part replacement to exoskeleton suit or robotics. In the case of collaborative robots (Co-Bots), robotics is used in collaboration with a human being to enable functions that would otherwise be prohibitive due to physical limitations.

Bionics represents the application of biological methods and systems found in nature, leverage to support the healthcare industry via electrically and/or mechanically powered artificial devices. Devices include artificial organs, body parts, and exoskeleton, which either replaces damaged or weakened body parts. These devices act as the original functions very closely. The exoskeleton suit has also been used in other purposes like rehabilitation and elder care.

This human augmentation report addresses the market for bionics, organ replacement, exoskeletons, and robotics in the healthcare sector including technology assessment, product and service review, application evaluation, industry impact assessment, and competitive analysis. The report includes detailed forecasts covering many aspects of human augmentation in healthcare for 2023 through 2028.

Companies in Report:

Table of Contents

1.0. Executive Summary

2.0. Introduction

• 1.1. Bionics Overview
• 1.2. Bionics Products and Application Industry
• 1.3. Bionics Growth Drivers
  • 1.3.1. Healthcare Technology Advancement
  • 1.3.2. Aging Population to Increase Organ Failure
  • 1.3.3. Accident to Amputations
  • 1.3.4. Exoskeleton Application
  • 1.3.5. Substitute of Robotics
  • 1.3.6. Government R&D Initiative
  • 1.3.7. Increase of Income Especially in Emerging Economies
• 1.4. Bionics Market Limitations
  • 1.4.1. High Cost of Device and Treatment
  • 1.4.2. Government Regulations and Strict Approval process
  • 1.4.3. Lack of Surgical Expertise
• 1.5. Bionics Impact on Society
  • 1.5.1. Positive Impact
  • 1.5.2. Negative Impact

2. Bionics Technology and Market Development

• 2.1. Medical Bionics Products
• 2.2. Orthotics and Prosthetics
• 2.3. Artificial Organ
• 2.4. Powered Exoskeleton
  • 2.4.1. Medical Exoskeleton
  • 2.4.2. Military Exoskeleton
  • 2.4.3. Assistive Exoskeleton
• 2.5. Human Bionics
• 2.6. Mechanical vs. Electronics Bionics
• 2.7. Artificial Implants vs. Wearable Bionics
• 2.8. 3D Printing and Bionics
• 2.9. Bionics and Artificial Intelligence
• 2.10. Nanotechnology and Bionics
• 2.11. Business Biomimetic
• 2.12. Cybernetic Organism
• 2.13. Bionics Industry Landscape

3. Use Cases and Examples

• 3.1. HELLEN-The Exoskeleton
• 3.2. Tracking and Predicting Epilepsy Seizures
• 3.3. Designing an Exoskeleton for Fitness
• 3.4. Robotic Exoskeleton Case Study
• 3.5. ReWalk Exoskeleton
• 3.6. Magnetic Encoders Allows the Building of 'Life-Changing' Exoskeletons
• 3.7. Indego Exoskeleton

4. Human Augmentation Market Analysis and Revenue Forecasts

• 4.1. Combined Bionics Revenue 2023-2028
• 4.2. Bionics Revenue by Industry Vertical 2023-2028
• 4.3. Medical Bionics Revenue 2023-2028
  • 4.3.1. Medical Bionics Revenue by Product Category
  • 4.3.2. Medical Bionics Revenue by Application Type
  • 4.3.3. Implantable Medical Bionics Revenue by Product Type
  • 4.3.4. Medical Bionics Revenue by Technology Type
  • 4.3.5. Medical Mechanical Bionics Revenue by Product Type
  • 4.3.6. Medical Bionics Revenue by End User Type
  • 4.3.7. Medical Bionics Revenue by Region
  • 4.3.8. North America Medical Bionics Revenue by Country
  • 4.3.9. Europe Medical Bionics Revenue by Country
  • 4.3.10. APAC Medical Bionics Revenue by Country
  • 4.3.11. LAMEA Medical Bionics Revenue by Country
• 4.4. Defense Exoskeleton Bionics Revenue 2023-2028
  • 4.4.1. Defense Exoskeleton Bionics Revenue by Product Category
  • 4.4.2. Defense Exoskeleton Bionics Revenue by Technology Type
  • 4.4.3. Defense Exoskeleton Bionics Revenue by Region
  • 4.4.4. North America Defense Exoskeleton Bionics Revenue by Country
  • 4.4.5. APAC Defense Exoskeleton Bionics Revenue by Country
  • 4.4.6. Europe Defense Exoskeleton Bionics Revenue by Country
  • 4.4.7. ROW Defense Exoskeleton Bionics Revenue by Country

5. Company and Analysis

• 5.1. Strategic Initiatives
• 5.2. Abbott Laboratories
• 5.3. AbbVie Inc.
• 5.4. Abiomed
• 5.5. Asahi Kasei Kuraray Medical Co. Ltd.
• 5.6. Baxter International
• 5.7. Zimmer Biomet Holdings
• 5.8. Boston Scientific Corporation
• 5.9. Cochlear Ltd.
• 5.10. Edwards Lifesciences Corporation
• 5.11. Ekso Bionics Holdings Inc.
• 5.12. LivaNova PLC
• 5.13. Medtronic plc
• 5.14. Orthofix Holdings Inc.
• 5.15. Otto Bock HealthCare GmBH
• 5.16. Sonova Holding AG
• 5.17. Ossur Corporate
• 5.18. SynCardia Systems LLC
• 5.19. Bionic Power
• 5.20. ExoAtlet
• 5.21. Lockheed Martin Corporation
• 5.22. RB3D
• 5.23. Sarcos Corporation
• 5.24. Spring Active
• 5.25. SRI International

6. Conclusions and Market Outlook

Figures

• Figure 1: Bionics Product and Application Ecosystem
• Figure 2: Bionics Industry Landscape
• Figure 3: Global Bionics Market Revenue 2023 - 2028

Tables

• Table 1: Global Bionics Revenue by Industry Vertical 2023 - 2028
• Table 2: Global Medical Bionics Revenue by Product Category 2023 - 2028
• Table 3: Global Orthopaedic Bionics Revenue by Product Type 2023 - 2028
• Table 4: Global Bionics Limbs Revenue by Product Type 2023 - 2028
• Table 5: Global Bionics Lower Limbs Revenue by Product Type 2023 - 2028
• Table 6: Global Electrical Bone Growth Stimulators Revenue by Product Type 2023 - 2028
• Table 7: Global Cardiac Bionics Revenue by Product Type 2023 - 2028
• Table 8: Global Artificial Organs Revenue by Product Type 2023 - 2028
• Table 9: Global Artificial Heart Valves Revenue by Product Type 2023 - 2028
• Table 10: Global Bionics Pacemaker Revenue by Product Type 2023 - 2028
• Table 11: Global Bionics Ventricular Assist Device (VADs) Revenue by Product Type 2023 - 2028
• Table 12: Global Neural/Brain Bionics Revenue by Product Type 2023 - 2028
• Table 13: Global Bionics Internal Neurostimulators Revenue by Product Type 2023 - 2028
• Table 14: Global Bionics Ear Revenue by Product Type 2023 - 2028
• Table 15: Global Medical Bionics Revenue by Application Type 2023 - 2028
• Table 16: Global Implantable Medical Bionics Revenue by Product Type 2023 - 2028
• Table 17: Global Externally Worn Medical Bionics Revenue by Product Type 2023 - 2028
• Table 18: Global Medical Bionics Revenue by Technology Type 2023 - 2028
• Table 19: Global Medical Mechanical Bionics Revenue by Product Type 2023 - 2028
• Table 20: Global Medical Electronic Bionics Revenue by Product Type 2023 - 2028
• Table 21: Global Medical Bionics Revenue by End User Type 2023 - 2028
• Table 22: Medical Bionics Revenue by Region 2023 - 2028
• Table 23: North America Medical Bionics Revenue by Country 2023 - 2028
• Table 24: Europe Medical Bionics Revenue by Country 2023 - 2028
• Table 25: APAC Medical Bionics Revenue by Country 2023 - 2028
• Table 26: SEA Medical Bionics Revenue by Country 2023 - 2028
• Table 27: LAMEA Medical Bionics Revenue by Country 2023 - 2028
• Table 28: Global Defense Exoskeleton Bionics Revenue by Product Category 2023 - 2028
• Table 29: Global Defense Exoskeleton Revenue by Technology Type 2023 - 2028
• Table 30: Defense Exoskeleton Bionics Revenue by Region 2023 - 2028
• Table 31: North America Defense Exoskeleton Bionics Revenue by Country 2023 - 2028
• Table 32: APAC Defense Exoskeleton Bionics Revenue by Country 2023 - 2028
• Table 33: Europe Defense Exoskeleton Bionics Revenue by Country 2023 - 2028
• Table 34: ROW Defense Exoskeleton Bionics Revenue by Country 2023 - 2028